A bisphosphonate monoamide analogue of DOTA: A potential agent for bone targeting

Journal of the American Chemical Society

Volumn 127, Issue 47, 2005, Pages 16477-16485

  Kubíček, Vojtěch ^a,b   Rudovsky, Jakub ^b   Kotek, Jan ^b   Hermann, Petr ^b   Elst, Luce Vander ^c   Muller, Robert N ^c   Kolar, Zvonimir I ^a   Wolterbeek, Hubert Th ^a   Peters, Joop A ^a   Lukeš, Ivan ^b  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CHELATION; COMPLEXATION; DERIVATIVES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SORPTION; SYNTHESIS (CHEMICAL);

HYDROXYAPETITE; LIGANDS; RELAXIVITY; ROTATIONAL CORRELATION;

AMINES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; AMIDE; BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; LANTHANIDE; MACROCYCLIC COMPOUND; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADSORPTION; ARTICLE; DIAGNOSTIC IMAGING; DRUG SYNTHESIS; DRUG UPTAKE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOCHEMISTRY; REACTION ANALYSIS; ROTATION;

ADSORPTION; AMIDES; BINDING, COMPETITIVE; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CHELATING AGENTS; DIPHOSPHONATES; DURAPATITE; GADOLINIUM; HETEROCYCLIC COMPOUNDS, 1-RING; LANTHANOID SERIES ELEMENTS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE;

EID: 28444439608     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja054905u     Document Type: Article

References (44)

1. Merbach, A. E., Tóth, E., Eds. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; John Wiley and Sons: New York, 2001.
2. Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Chem. Rev. 1999, 99, 2293-2352.
3. Aime, S.; Botta, M.; Fasano, M.; Terreno, E. Chem. Soc: Rev. 1998, 27, 19-29.
4. Weissleder, R.; Mahmood, U. Radiology 2001, 219, 316-333.
5. Jacques, V.; Desreux, J. F. Top. Curr. Chem. 2002, 221, 123-164.
6. Aime, S.; Cabella, C.; Colombatto, S.; Crich, S. G.; Gianolio, E.; Maggioni, F. J. Magn. Reson. Imaging 2002, 16, 394-406.
7. Fleisch, H. Bisphosphonates in Bone Disease, 4th ed.; Academic Press: London, 2000.
8. Adzamli, I. K.: Gries, H.; Johnson, D.; Blau, M. J. Med. Chem. 1989, 32, 139-144.
9. Adzamli, I. K.; Johnson, D.; Blau, M. Invest. Radiol. 1991, 26, 143-148.
10. Adzamli, I. K.; Blau, M.; Pfeffer, M. A.; Davis, M. A. Magn. Reson. Med. 1993, 29, 505-511.
11. Greb, W.; Blum, H.; Roth, M. PCT WO2003/097074, 2003; Chem. Abstr. 2003, 931193.
12. Adzamli, I. K.; Blau, M. Magn. Reson. Med. 1991, 17, 141-148.
13. Bligh, S. W. A.; Harding, C. T.; McEwen, A. B.; Sadler, P. J.; Kelly, J. D.; Marriott, J. A Polyhedron 1994, 13, 1937-1943.
14. Alves, F. C1; Donato.P.; Sherry, A. D.; Zaheer, A.; Zhang, S.; Lubag, A. J. M.; Merritt, M. E.; Lenkiski, R. E.; Frangioni. J. V.; Neves, M.; Prata, M. I. M.; Santos, A. C.; de Lima, J. J. P.; Geraldes, C. F. G. C. Invest. Radiol. 2003, 38, 750-760.
15. Dadabhoy, A.; Faulkner, S.; Sammes. P. G. J. Chem. Soc., Perkin Trans. 2 2002, 348-357.
16. Kantoci, D.; Denike, J. K.; Wechter W. J. Synth. Commun. 1996, 26, 2037-2043.
17. Corsi, D. M.; Platas-Iglesias, C.; van Bekkum, H.; Peters, J. A. Magn. Reson. Chem. 2001, 39, 723-726.
18. Zitha-Bovens, E.; Vander Elst, L.; Muller, R. N.; van Bekkum, H.; Peters, J. A. Eur. J. Inorg. Chem. 2001, 3101-3105.
19. Meiboom, S.; Gill, D. Rev. Sci. Instrum. 1958, 29, 688-691.
20. Kotek, J.; Lebdušková, P.; Hermann, P.; Vander Elst, L.; Muller, R. N.; Maschmeyer, T.; Lukeš, I.; Peters, J. A. Chem. Eur. J. 2003, 9, 5899-5915.
21. Moreau, J.; Guillon, E.; Pierrard, J.-C.; Rimbault, J.; Port, M.; Aplincourt, M. Chem. Eur. J. 2004, 10, 5218-5232.
22. Bollinger, J. E.; Roundhill, D. M. Inorg. Chem. 1993, 32, 2821-2826.
23. Zeevaart, J. R.; Jarvis, N. V.; Louw, W. K. A.; Jackson, G. E.; Cukrowski, I.; Mouton, C. J. J. Inorg. Biochem. 1999, 73, 265-272.
24. Tóth, E.; Brücher, E.; Lazar, I.; Tóth, I. Inorg. Chem. 1994, 33, 4070-4076.
25. Aime, S.; Botta M.; Ermondi, G. Inorg. Chem. 1992, 31, 4291-4299.
26. Howard, J. A. K.; Kenwright, A. M.; Moloney, J. M.; Parker, D.; Port, M.; Navet, M.; Rousseau, O.; Woods, M. Chem. Commun. 1998, 13, 1381-1382.
27. Aime, S.; Botta, M.; Fasano, M.; Marques, M. P. M.; Geraldes, C. F. G. C.; Pubanz, D.; Merbach, A. E. Inorg. Chem. 1997, 36, 2059-2068.
28. Aime, S.; Botta, M.; Garino, E.; Geninatti Crich, S.; Giovenzana, G.; Pagliarin, R.; Palmisano, G.; Sisti, M. Chem. Eur. J, 2000, 6, 2609-2617.
29. Peters, J. A.; Huskens, J.; Raber, D. J. Prog. NMR Spectrosc. 1996, 28, 283-350.
30. Kieboom, A. P. G.; van der Toorn, J. M.; Peters, J. A.; Bovée, W. M. M. J.; Sinnema, A.; Vijverberg, C. A. M.; van Bekkum, H. Recl. Trav. Chim. Pays-Bas 1978, 97, 247.
31. Alpoim, M. C.; Urbano, A. M.; Geraldes, C. F. G. C.; Peters, J. A. J. Chem. Soc., Dalton Trans. 1992, 463.
32. Dyba, M.; Kozlowksi, H.; Tlalka, A.; Leroux, Y.; El Manouni, D. Pol. J. Chem. 1998, 72, 1148-1153.
33. Vaňura, P.; Jedináková- Křížová, V.; Hakenová, L.; Munesawa, Y. J. Radioanal. Nucl. Chem. 2000, 246, 689-692.
34. Powell, D. H.; Dhubhghaill, O. M. N.; Pubanz, D.; Helm, L.; Lebedev, Y. S.; Schlaepfer, W.; Merbach, A. E. J. Am. Chem. Soc. 1996, 118, 9333-9346.
35. Botta, M. Eur. J. Inorg. Chem. 2000, 399-407.
36. Rudovský, J.; Cígler, P.; Kotek, J.; Hermann, P.; Vojtíšek, P.; Lukeš, I.; Peters, J. A.; Vander Elst, L.; Muller, R. N. Chem. Eur., J. 2005, 11, 2373-2384.
37. Rudovsky, J.; Kotek, J.; Hermann, P.; Lukeš, I.; Mainero, V.; Aime, S. Org. Biomol. Chem. 2005, 3, 112-117.
38. Aime, S.; Botta, M.; Fasano, M.; Terreno, E. Acc. Chem. Res. 1999, 32, 941-949.
39. Aime, S.; Gianolio, E.; Barge, A.; Kostakis, D.; Plakatouras, I. C.; Hadjiljadis, N. Eur. J. Inorg. Chem. 2003, 2045-2048.
40. Langmuir, I. J. Am. Chem. Soc. 1918, 40, 1361-1403.
41. Li, W. P.; Ma, D. S.; Higginbotham, C.; Hoffman, T.; Ketring, A. R.; Cutler, C. S.; Jurisson, S. S. Nucl. Med. Biol. 2001, 28, 145-154.
42. Claessens, R. A. M. J.; Kolar, I. Z. Langmuir 2000, 76, 1360-1367.
43. HyperChem Release 7.5 for Windows, Molecular Modeling System; Hypercube, Inc., 2002.
44. The high relaxivity of HA at low field can be explained by the long correlation time modulation of dipole-dipole relaxation of protons. This very long correlation time is due to the adsorption equilibrium of the water molecules on the surface of HA and to their subsequent slow motion. The same trend is observed with colloidal suspensions of silica beads. Roose, P.: van Craen, J.: Finsy, R.; Eisendraht, H. J. Magn. Reson. A 1995, 115, 20.